-

EvoEndo Elects David Pierce to the Board of Directors

DENVER--(BUSINESS WIRE)--EvoEndo®, Inc. (“EvoEndo”), a medical device company developing platforms for Unsedated Transnasal Endoscopy (TNE), is proud to announce that David Pierce has joined our Board of Directors.

Mr. Pierce brings a wealth of experience and wisdom from his 30-year track record of success at Boston Scientific and his current activity as an Independent Trustee with Diversified Healthcare Trust. He has a deep level of knowledge in the field of endoscopy and understands what it takes to drive long-term profitable growth.

During his long tenure at Boston Scientific, Mr. Pierce’s roles included Executive Vice President and President of MedSurg, President of Endoscopy, Senior Vice President and President of the Urology Division, and Senior Vice President and President of the Endoscopy Division.

“We are extremely pleased to have the opportunity to work with Dave Pierce,” said CEO Jonathan Hartmann. “Dave understands how to successfully penetrate and grow new markets with novel technologies aimed at providing patients and physicians with exceptional clinical outcomes.”

Mr. Pierce is a trustee of Norwich University and previously served as a director of the Medical Device Manufacturers Association and MassMedic. He was the strategic advisory board chair of the American Gastroenterology Association Center for GI Innovation and a director of the American Society of Gastrointestinal Endoscopy Foundation. Mr. Pierce attained the rank of Captain in the United States Army.

Mr. Pierce's experience, leadership, and accomplishments will be extremely valuable to EvoEndo as we execute our mission of enabling unsedated endoscopy.

About EvoEndo®

EvoEndo®, Inc. is a medical device company developing sterile single-use, flexible endoscopes that enable unsedated endoscopic procedures. EvoEndo’s technology allows pediatric patients and adults to consider an unsedated option for routine endoscopies in a clinic setting without general anesthesia or sedation. To learn more, please visit https://evoendo.com.

Contacts

EvoEndo®, Inc.
Annie Harmon
Senior Director of Marketing & Communications
aharmon@evoendo.com
303.350.2068

Industry:

EvoEndo, Inc.

Release Summary
EvoEndo, a medical device company developing platforms for Unsedated Transnasal Endoscopy (TNE), announces David Pierce on Board of Directors.
Release Versions
English
Hashtags
#Endoscopy
#EvoEndo
#TNE

Contacts

EvoEndo®, Inc.
Annie Harmon
Senior Director of Marketing & Communications
aharmon@evoendo.com
303.350.2068

Social Media Profiles
EvoEndo on Facebook
EvoEndo on LinkedIn
EvoEndo on YouTube
More News From EvoEndo, Inc.

EvoEndo® Expands Access to Sedation-Free Endoscopy Across Gastroenterology Programs of All Sizes

CHICAGO--(BUSINESS WIRE)--EvoEndo®, Inc. (EvoEndo) today announced that sedation-free transnasal endoscopy (TNE) is reaching a broader range of gastroenterology programs, including clinic settings without dedicated anesthesia coverage or operating room access. Because the EvoEndo Endoscopy System does not require sedation, programs of nearly any size can offer diagnostic evaluation and monitoring in their own clinic setting. “A sedation-free alternative to traditional endoscopy changes where ca...

EvoEndo® Surpasses 3,000 Sedation-Free Transnasal Endoscopy Procedures Nationwide

CHICAGO--(BUSINESS WIRE)--EvoEndo®, Inc. (EvoEndo) today announced that practitioners have now completed more than 3,000 sedation-free transnasal endoscopy (TNE) procedures using the EvoEndo Endoscopy System, as implementation expands to more than 70 locations nationwide. “Reaching 3,000 cases is an important milestone, but what matters most is what it represents for patients, families, and physicians,” said Jonathan Hartmann, CEO of EvoEndo. “Every case reflects greater access to sedation-free...

Nicklaus Children's Hospital is First in Region to Offer Sedation-Free Evaluation of Upper Gastrointestinal Tract in Children

DENVER--(BUSINESS WIRE)--EvoEndo®, Inc. (EvoEndo) announces that Nicklaus Children’s Hospital is the first in South Florida to offer sedation-free transnasal endoscopy (TNE) using the EvoEndo System to evaluate the upper digestive tract in children. TNE can be used as an alternative to traditional upper endoscopy performed through the mouth for patients and their families who prefer to avoid sedation and the associated inconveniences. A sedation-free alternative is more convenient for patients...
Back to Newsroom